Bluejay Diagnostics, Inc.
BJDX · XNASCIK 1704287fmd_0NWH0T5WPVRV2QJKHX2DR2ZNXJManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | – | – | – |
| Net interest income | (0) | (0) | – | – | – | – |
| Cost of revenue | – | – | 0 | – | – | – |
| Gross profit | – | – | 0 | – | – | – |
| Research and development | 1 | 1 | 4 | 6 | 3 | 3 |
| Selling, general and administrative | 1 | 2 | 0 | 5 | 4 | – |
| Total operating expenses | 1 | 3 | 9 | 10 | 7 | 7 |
| Operating income | (1) | (3) | (9) | (10) | (7) | (7) |
| Interest expense | 0 | 0 | – | – | 1 | 0 |
| Interest and investment income | – | – | – | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | (0) | 0 | 0 | (1) | 0 |
| Net income | (1) | (3) | (9) | (10) | (8) | (7) |
| Net income to common shareholders | – | – | – | (10) | (21) | (7) |